According to the research report titled ‘Asia Pacific Protein A Resins Market Share By Product, End-use, Application, Matrix Type, Industry Analysis Report, Regional Outlook, Application Potential, Competitive Market Share & Forecast, 2020 – 2026’, available with Market Study Report, Asia Pacific protein A resins market is predicted to be worth USD 120 million by the year 2026.
 

Widespread usage of chromatography for identification and purification of biological strains are impelling the growth of Asia Pacific protein A resins market. Benefits such as cost-effectiveness and better efficiency, alongside extensive acceptability of protein A resins are further boosting the market share.
 

Request sample copy of this Report: https://www.marketstudyreport.com/request-a-sample/2609888/
 

Biopharmaceutical organizations are making investments in research activities and focusing on development of novel therapeutics, which along with strong pipeline of emerging pharmaceutical companies are bolstering the demand for protein A resins across APAC. Though, on the contrary, high cost of the product and availability of alternatives will restrain the industry growth over 2020-2026.
 

Speaking of product landscape, recombinant accounted for 60% revenue share in the year 2019 and poised to gain further traction in the ensuing years. The product is obtained from E. coli bacteria and known to offer purification & detection as compared to natural protein A resins.
 

Moving on application spectrum, Asia Pacific protein A resins market from antibody purification segment was worth USD 85 million in 2019, on account of surging therapeutic & diagnostic applications of monoclonal antibodies. Inflowing investments towards research & development of advanced antibodies for treatment of rare & autoimmune diseases will spur the segmental share.
 

Considering the matrix type, glass/silica gel-based segment of Asia Pacific protein A resins industry is reckoned to grow with a CAGR of 8.5% over the study duration, owing to superior mechanical strength, enhanced durability, and high absorption capability for metallic dopants of this matrix. Also, glass powder matrix facilitates nucleic acid purification, hence stimulating product popularity.
 

Based on end-use scope, Asia Pacific protein A resins market demand from research institutes is projected to amplify at the rate of 9% annually over the forecast period. Surge in demand can be credited to numerous research programs across medical sector for development of biochemicals in academia, alongside increasing usage of chromatography.
 

Geographically, protein A resins market size in Japan was remunerated at USD 38 million in 2019 and is estimated to showcase robust growth trends over 2020-2026, attributed to constant innovations in biopharma and pharmaceutical sector. High spending capacity leading swift adoption of next-gen technology products will sway forward the business dynamics in Japan.
 

Major contenders in Asia Pacific protein A resins market sphere are Tosoh Biosciences LLC, Thermo Fisher Scientific, Purolite Life Sciences, Takara Bio Inc., Novasep, Sigma-Aldrich Corp., Repligen, GenScript Corp., GE Healthcare, EMD Millipore, Expedeon Ltd., Danaher Corp., Bio-Rad Laboratories Inc., and Agarose Bead Technologies.